HomePSYBF • OTCMKTS
add
Psybio Therapeutics Corp
Previous close
$0.00010
Year range
$0.00010 - $0.027
Market cap
629.63K CAD
Avg Volume
7.10K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 131.99K | -90.01% |
Net income | -181.99K | 87.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -137.98K | 89.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 12.37K | -98.64% |
Total assets | 283.14K | -78.11% |
Total liabilities | 1.97M | 55.92% |
Total equity | -1.69M | — |
Shares outstanding | 132.61M | — |
Price to book | -0.01 | — |
Return on assets | -134.65% | — |
Return on capital | 24.90% | — |
Cash Flow
Net change in cash
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -181.99K | 87.34% |
Cash from operations | -361.72K | 72.27% |
Cash from investing | 622.00 | -99.95% |
Cash from financing | 558.71K | 549.57% |
Net change in cash | -56.58K | -13.59% |
Free cash flow | -45.57K | 91.76% |
About
Founded
2009
Headquarters
Website
Employees
4